Richard J. Young
305 Grattan Street
Melbourne, VIC, Australia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
Journal: Nature communications
Published: November 21, 2025
Evaluating CD103+ intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal Cancer.
Journal: Oral oncology
Published: October 29, 2025
Examining CD103+ Tissue-Resident Memory T Cells in Nasopharyngeal Carcinoma.
Journal: Head & neck
Published: February 17, 2025
Characterizing and Targeting of BCL-2 Family Members in Nasopharyngeal Carcinoma.
Journal: Head & neck
Published: April 03, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors.
Journal: Cancers
Published: January 25, 2024
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis.
Journal: Communications biology
Published: July 12, 2023
Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinoma.
Journal: The British journal of dermatology
Published: March 29, 2023
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: February 02, 2023
Prognostic stratification of HPV-associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomized trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 09, 2022
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
Journal: Journal for immunotherapy of cancer
Published: August 20, 2021
Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.
Journal: Oral oncology
Published: July 30, 2020
Last Updated: 09/26/2026